2 unknown. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 2 | Unknown 2 |
Follow Immunogenicity: new trials by email Literature Review of Immunogenicity trials Research Report on Immunogenicity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2 Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2; - Immunogenicity, Safety | Phase 2 / Phase 3 | Unknown | Stemirna Therapeutics | 800 | 2023-06-20 | 2023-06-20 |
| Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants Trivivac vaccine - Immunogenicity, Reactogenicity | Phase 2 / Phase 3 | Unknown | Queen Sirikit National Institute of Child Health | 200 | 2012-09-01 | 2013-01-08 |
Infections (1) · Mononegavirales Infections (1) · Morbillivirus Infections (1) · Paramyxoviridae Infections (1) · RNA Virus Infections (1) · Rubivirus Infections (1) · Togaviridae Infections (1) · Virus Diseases (1)
Queen Sirikit National Institute of Child Health (1) · Stemirna Therapeutics (1)
Thailand (1)